Skip to content

SUBSCRIBE
MEMBERS AREA
SPIN-OFF CALENDAR
RESOURCES
ABOUT

BXRX

Buy Recro Pharma (REPH)

Rich Howe2019-11-25T11:25:17-05:00

November 25, 2019

Learn More

HOME
BLOG
ABOUT
LEGAL
RESOURCES

Rich HoweFollow

I research micro caps and special situations at https://t.co/DPLkAsgVH8.

Rich Howe @stockspinoffss·

How I analyze insider incentives for new spinoffs:

1) open Form 10 filing
2) open Ex-99.1
3) go to “executive compensation”
4) find number of shares reserved for management and employee incentives.

Example shown: Nuvectra (NVTR)

Reply on Twitter 1452953188689235972 Retweet on Twitter 145295318868923597216 Like on Twitter 1452953188689235972125 Twitter 1452953188689235972

Rich Howe @stockspinoffss·

Not only do spin-offs go unnoticed by most investors.

But they go unnoticed despite considerable praise from many Superinvestors.

Here's what 6 Superinvestors had to say about spinoffs.

First up, broadly recognized as the best investor of all time👇

Reply on Twitter 1451865995145064448 Retweet on Twitter 14518659951450644489 Like on Twitter 145186599514506444830 Twitter 1451865995145064448

Rich Howe @stockspinoffss·

Monthly round up of spin-offs with insider buying!

A few new names on the list: $NHF and $VTSCY

Any others on your watch list?

https://stockspinoffinvesting.com/spin-offs-with-insider-buying-october-2021/

Reply on Twitter 1451197160876232714 Retweet on Twitter 1451197160876232714 Like on Twitter 145119716087623271412 Twitter 1451197160876232714

Rich Howe @stockspinoffss·

Calling all my technical analysis fintwit peeps!

Thoughts on this chart? #TGA Thungela

TGA looks good from val perspective (0.8x NTM FCF), and I think it looks good from a technical perspective UNLESS it breaks its 50day moving avg.

Agree? Disagree?

cc: @marketplunger1

Reply on Twitter 1450815558388158479 Retweet on Twitter 1450815558388158479 Like on Twitter 145081555838815847912 Twitter 1450815558388158479

Rich Howe @stockspinoffss·

EVERYTHING YOU NEED TO KNOW ABOUT LEAPS

-What LEAPS are
-Why they are often inefficiently priced during spin-offs
-When to use them
-A Greenblatt case study
-Plus...an opportunity to use LEAPS to play $GSK’s upcoming 2022 consumer spinoff

// THREAD //

Reply on Twitter 1450416449084870660 Retweet on Twitter 14504164490848706608 Like on Twitter 145041644908487066061 Twitter 1450416449084870660

Custom Twitter Feeds Plugin

©2020 STOCKSPINOFFINVESTING.COM | [whelk] helped!